Your Input: | |||||
BRCA2 | LOW QUALITY PROTEIN: breast cancer type 2 susceptibility protein. (3391 aa) | ||||
EP300 | Histone acetyltransferase p300. (2174 aa) | ||||
TOPORS | E3 ubiquitin-protein ligase Topors isoform X1. (1044 aa) | ||||
BAG6 | Large proline-rich protein BAG6 isoform X1. (1162 aa) | ||||
USP28 | Ubiquitin carboxyl-terminal hydrolase 28 isoform X4; Belongs to the peptidase C19 family. (1077 aa) | ||||
SHISA5 | Protein shisa-5 isoform X1. (235 aa) | ||||
PYCARD | Apoptosis-associated speck-like protein containing a CARD isoform X1. (194 aa) | ||||
NUPR1 | Nuclear protein 1. (99 aa) | ||||
HIPK2 | Homeodomain-interacting protein kinase 2 isoform X1. (1198 aa) | ||||
ATAD5 | ATPase family AAA domain-containing protein 5-like. (1204 aa) | ||||
MSH2 | DNA mismatch repair protein; Component of the post-replicative DNA mismatch repair system (MMR). (925 aa) | ||||
SIRT1 | NAD-dependent protein deacetylase sirtuin-1 isoform X1. (729 aa) | ||||
AEN | Apoptosis-enhancing nuclease. (325 aa) | ||||
ELL3 | RNA polymerase II elongation factor ELL3. (394 aa) | ||||
PML | Protein PML. (885 aa) | ||||
PHLDA3 | Pleckstrin homology like domain family A member 3. (127 aa) | ||||
TMEM109 | Transmembrane protein 109. (244 aa) | ||||
HIPK1 | Homeodomain-interacting protein kinase 1 isoform X1. (1210 aa) | ||||
ENSTSYP00000018602 | annotation not available (632 aa) | ||||
ENSTSYP00000020409 | annotation not available (369 aa) | ||||
ENSTSYP00000022986 | annotation not available (803 aa) | ||||
TP73 | Tumor protein p73; Participates in the apoptotic response to DNA damage. Isoforms containing the transactivation domain are pro-apoptotic, isoforms lacking the domain are anti-apoptotic and block the function of p53 and transactivating p73 isoforms. May be a tumor suppressor protein. (637 aa) | ||||
TP53 | Cellular tumor antigen p53; Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression; Belongs to the p53 family. (388 aa) | ||||
DDIT4 | DNA damage-inducible transcript 4 protein isoform X1. (231 aa) | ||||
ENSTSYP00000024826 | annotation not available (506 aa) | ||||
CHEK2 | Serine/threonine-protein kinase Chk2 isoform X1. (582 aa) | ||||
TP63 | Tumor protein 63 (p63); Acts as a sequence specific DNA binding transcriptional activator or repressor. The isoforms contain a varying set of transactivation and auto-regulating transactivation inhibiting domains thus showing an isoform specific activity. May be required in conjunction with TP73/p73 for initiation of p53/TP53 dependent apoptosis in response to genotoxic insults and the presence of activated oncogenes. (690 aa) | ||||
CDKN1A | Cyclin-dependent kinase inhibitor 1. (164 aa) | ||||
PPP2R5C | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit; The B regulatory subunit might modulate substrate selectivity and catalytic activity, and also might direct the localization of the catalytic enzyme to a particular subcellular compartment. (556 aa) | ||||
SNW1 | SNW domain-containing protein 1 isoform X2. (536 aa) |